應用Hugo RAS機器人系統在機器手臂輔助根治性攝護腺切除術：一位外科醫生的經驗分享

劉品均、林益聖、歐宴泉、許兆畬、童敏哲

童綜合醫院外科部泌尿科

Exploring the Implementation of the Innovative Hugo RAS Robot System in Robotic-Assisted Radical Prostatectomy: Insights from a Single Surgeon's Practice

Pin-Chun Liu, Yi-Sheng Lin, Yen-Chuan Ou, Chao-Yu Hsu, Min-Che Tung

Dept. of Urology, Tungs’ Taichung Metroharbor Hospital, Taichung, Taiwan

Purpose:

Radical prostatectomy is the standard treatment of localized prostate cancer. Several new robotic platforms have been announced in recent years. The Hugo RAS system (Medtronic, Minneapolis, MN, USA) was approved for urologic surgery in Taiwan in May 2023. This study aims to explore the surgical outcomes of robotic-assisted radical prostatectomy (RARP) between the novel Hugo robotic system and the Da Vinci system.

Materials and Methods:

We retrospectively collected data on patients who underwent RARP (using either the Hugo or Da Vinci system) from May 2023 to March 2024, performed by a single surgeon. Baseline characteristics, including age, BMI, prostate size, and preoperative PSA level as well as perioperative outcomes (surgical time, blood loss, number of lymph node retrieved and positive surgical margins) were collected and analyzed using T tests and Chi-Squared test with SPSS software.

Results:

This study analyzed data from 155 patients who underwent RARP, with 59 procedures performed using the Hugo system and 96 using the Da Vinci system. RARP with the Hugo system tended to involve a younger patient population (66.8 v.s. 69.8, P=0.015) compared to procedures performed with the Da Vinci system. However, factors such as BMI, estimated blood loss, surgical duration, length of hospital stay, number of retrieved lymph nodes, and positive margin rate did not demonstrate statistical significance between the two systems.

Conclusion:

Hugo RARP had similar surgical outcomes, such as estimated blood loss, operative time, the rate of positive surgical margin and days in hospital were noted when compared with Da Vinci RARP. This study demonstrated that the Hugo RAS is a safe and feasible platform for RARP.